NVIDIA's Performance and Market Impact - NVIDIA's stock soared 171% in 2024, significantly outperforming the S&P 500's 25% return [2] - The company accounted for more than one-fifth of the S&P 500's 2024 gain due to its massive weighting in the index [2] - Despite strong earnings beats in August and November, the stock traded sideways through the end of 2024 [2] AI and Industry Trends - AI continues to be a dominant theme, with over 40% of S&P 500 companies citing AI on earnings calls by Q2 2024 [6] - Non-tech firms are increasingly adopting AI, as highlighted by NVIDIA CEO Jensen Huang's statement that "every industry will become a technology company" [5][6] - The semiconductor industry, particularly NVIDIA, has been a major beneficiary of the AI-driven tech revolution [1] Upcoming Events and Catalysts - NVIDIA's CEO Jensen Huang will deliver a keynote at CES on January 6, 2025, showcasing robotics innovations, RTX 50xx gaming graphics cards, and potential entry into the AI PC market [4] - The company will also participate in a fireside chat with analysts at J P Morgan and hold a financial analyst Q&A during CES [4] - Investors are closely watching for updates on Blackwell chips, including potential defects and production delays, which impacted shares in the second half of 2024 [4] Financial Outlook and Analyst Expectations - NVIDIA is expected to report fiscal Q4 2025 results on February 26, with consensus estimates calling for $0 85 in non-GAAP EPS, marking 64% bottom-line growth [9] - For FY 2025, per-share earnings are expected to rise by 128% to $2 95, with 50% EPS growth projected for the following year [9] - Bank of America forecasts a 50% sales increase for NVIDIA in 2025, potentially making it the fastest top-line grower in the S&P 500 [9] Market Volatility and Investor Focus - NVIDIA's implied volatility heading into CES was 45%, down from peak levels of 70-80% in August and September 2024 [4] - Investors are bracing for potential volatility around key events, including CES and the J P Morgan Healthcare Conference, as well as the upcoming Q4 earnings report [4][10]

Key TakeawaysNvidia shares climbed to close at an all-time high Monday.The gains came after Nvidia supplier Foxconn posted record fourth-quarter revenue.CEO Jensen Huang is also set to deliver the opening keynote at a major consumer electronics show Monday evening. Nvidia (NVDA) shares climbed to close at an all-time high Monday after Taiwan's Foxconn reported record fourth-quarter revenue.  Foxconn, a key supplier for Nvidia, Apple (AAPL), and many other tech giants, posted fiscal fourth-quarter revenue th ...

Warren Buffett's great investment success can be attributed to what he once said, “If you make a couple of good decisions during a lifetime and avoid serious mistakes.” For many investors, the above is probablyAdvanced education in economics, business management and engineering. Professional experience with product management and development in high tech industry, including advisory with multiple fintech startups. Have been investing in growth companies since 1998. Recent interest of investment also include ...

A couple of developments appear to be fueling the AI specialist's rise.Nvidia (NVDA 4.58%) stock hit a new all-time high Monday morning, shaking off its mid-December slump and jumping as much as 5.3%. As of 1:19 p.m. ET, the stock was still up 4.7%.There were a couple of developments that sent the artificial intelligence (AI) chipmaker higher, as shareholders eagerly await an update from the company's rock star CEO.Kicking off CESCES is one of the biggest tech-focused events in the world. The annual trade s ...

Up more than 200% over the last year, can Nvidia stock keep delivering wins?Nvidia (NVDA 4.74%) stock is seeing strong gains in Monday's trading. The company's share price was up 4.7% as of 12:30 p.m. ET. Meanwhile, the S&P 500 (^GSPC 0.92%) was up 1.1%, and the Nasdaq Composite (^IXIC 1.44%) was up 1.6%.Nvidia stock is climbing today following a fourth-quarter report from Foxconn (otherwise known as Hon Hai Precision Industry) that suggests demand continues to be very strong in the artificial intelligence ...

I have worked in investment banking for almost a decade, before I decided to fully turn my attention to the stock market and my private investments. As a contributor to Seeking Alpha, my articles have a focus on accounting and financial analysis. I am an ex-colleague and close friend of Cavenagh Research, who also writes on Seeking Alpha.Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the ne ...

Nvidia will be present at an upcoming event for healthcare analysts.In today's video, I discuss Nvidia (NVDA 4.45%) and recent updates affecting the company. To learn more, check out the short video, consider subscribing, and click the special offer link below.*Stock prices used were the after-market prices of Jan. 3, 2025. The video was published on Jan. 5, 2025. ...

EnglishItalianoEspañolPortuguêsDeutschالعربيةFrançaisImportant DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your ...

At the heart of Arbe's innovation is its AI-powered processing of an exceptionally dense, high-resolution point cloud. Arbe's Perception Radar supports tens of thousands of detections per frame, powered by a massive MIMO array of 48 receiving and 48 transmitting channels. This enables ultra-high resolution in both azimuth and elevation, providing long-range detection capabilities in all weather and lighting conditions, with minimal false alarms. Arbe's perception radar offers unique capabilities, such as de ...

Company Leadership and Expertise - John Finn, a globally-recognized leader in cell and gene therapy with over 25 years of experience, joins Basecamp Research as Chief Scientific Officer (CSO) [1][2] - Finn has a strong background in advancing gene and cell therapy through innovations in delivery and editing technologies, having held senior positions at Tome Biosciences, Codiak BioSciences, and Intellia Therapeutics [2] - Konstantinos Andrikopoulos, with 27 years of pharma IP experience, joins as Senior Vice President for Intellectual Property, further strengthening the company's leadership team [5] Expansion and Infrastructure - Basecamp Research establishes a new lab and office in Kendall Square, Cambridge, Mass., to expand its network of therapeutic partnerships and validate sophisticated biological systems [1][4] - The company has built one of the most advanced industrial compute infrastructures in Europe, featuring NVIDIA H200 GPUs, to support the training of long-context AI foundation models [7] - The company's proprietary foundational dataset has expanded rapidly, collecting 10 times more data in the last three months than in the previous three years, thanks to a $60 million Series B funding round [6] AI and Data-Driven Innovation - Basecamp Research is developing new classes of foundational AI models to tackle complex biological design challenges, leveraging its vast and unique dataset [6][7] - The company operates one of the world's largest commercial biodiscovery programs, spanning over 120 locations in more than 25 countries, to provide AI models with a comprehensive understanding of biology [8] - Basecamp Research collaborates with top institutions and pharmaceutical companies, including a multi-year partnership with Dr. David R. Liu at the Broad Institute of MIT and Harvard, to design novel protein sequences and biological systems [9] Industry Impact and Vision - Basecamp Research aims to advance programmable genetic medicines by combining its proprietary data and powerful AI models, addressing challenges in the field of life sciences [3][6] - The company's approach to exploring beyond known biology and leveraging AI to design complex biological systems has the potential to transform therapeutic research and development [10] - Basecamp Research has been recognized as one of Bloomberg's "Top 25 UK Startups to Watch" for 2024, highlighting its innovative contributions to the industry [10]